Research Overview: HGH Fragment 176-191
HGH Fragment 176-191 is a synthetic peptide consisting of amino acids 176-191 from human growth hormone’s C-terminus. This laboratory-grade compound retains specific biological properties of the parent hormone while exhibiting distinct molecular characteristics. Researchers at Stroid UK Shop can investigate this fragment’s unique properties in controlled laboratory environments. The 5mg Beligas formulation provides consistent dosing for experimental protocols examining growth factor pathways and cellular metabolism. Studies have demonstrated that this fragment maintains lipolytic activity without the insulin-like effects associated with full-length growth hormone, making it valuable for researchers investigating selective biological mechanisms.
Laboratory Applications
Research teams utilise HGH Fragment 176-191 to examine lipolytic pathways, adipocyte metabolism, and growth hormone receptor interactions in cellular models. The fragment’s selective properties allow researchers to study specific aspects of growth hormone signalling without confounding variables. Laboratory investigations focus on its effects on adipose tissue metabolism, cellular energy expenditure, and growth factor receptor binding kinetics. Comparative studies with other peptides help researchers understand structure-activity relationships within the growth hormone family. This compound serves as a valuable tool for examining metabolic pathways in both in-vitro cell culture systems and controlled laboratory models, providing insights into selective growth hormone fragment activity.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | 1815.08 g/mol |
| CAS Number | Verify with supplier |
| Purity | ≥98% (HPLC) |
| Form | Lyophilised powder |
| Storage | -20°C long-term, 2-8°C short-term |
| Solubility | Water soluble |
| Sequence | YLRIVQCRSVEGSCGF |
| Manufacturer | Beligas Pharmaceuticals |
Research applications often compare this compound with other growth hormone derivatives available in our fragment peptide collection. The Beligas formulation undergoes rigorous quality control testing to ensure consistency across research batches. Analytical certificates document purity levels and confirm the absence of bacterial endotoxins, making it suitable for sensitive laboratory applications. Researchers can also explore complementary compounds in our SARMS category for comprehensive metabolic studies.
Laboratory Compliance
HGH Fragment 176-191 5mg Beligas is manufactured exclusively for in-vitro research applications in licensed laboratory facilities. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines and maintain appropriate laboratory safety protocols when handling this compound.
